mounjaro semaglutide or tirzepatide vs for Weight Loss Treatment Weight Loss Injections: Is it
Description
The SELECT trial associated semaglutide with reduced major cardiovascular events in certain high-risk populations
In essence, Maher expressed concerns about the drug, implying that medical professionals and scientists don't fully understand its mechanism of action, which could be unsettling for potential users
They can slow gastric emptying, potentially affecting absorption of oral meds, but clinically this is rarely significant
What is the minimum order quantity
The same trial also notes that the SEMALEAN study (2025): "Patients experienced an average weight loss of 12 kg after 6 months of treatment with Semaglutide", showing significant total-body change along with the internal change
Its also approved for pediatric patients (12+ years, 60 kg) with severe obesity, based on international standards
